Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155204564> ?p ?o ?g. }
- W2155204564 endingPage "4566" @default.
- W2155204564 startingPage "4554" @default.
- W2155204564 abstract "NFkB activity is critical for survival and proliferation of normal lymphoid cells and many kinds of B-cell tumors, including multiple myeloma (MM). NFkB activating mutations, which are apparent progression events, enable MM tumors to become less dependent on bone marrow signals that activate NFkB. Mutations that activate NFkB-inducing kinase (NIK) protein are the most prevalent among the many kinds of NFkB mutations in MM tumors. NIK is the main activating kinase of the alternative NFkB pathway, although over-expression of NIK also can activate the classical pathway. Two NIK inhibitors and an isomeric control were tested with human myeloma cell lines. These specific NIK inhibitors are selectively cytotoxic for cells with NIK-dependent activation of NFkB. Combination therapy targeting NIK and IKKbeta (as a main kinase of the classical NFkB pathway) represents a promising treatment strategy in MM. NIK inhibitors can also be useful tool for assessing the role of NIK and alternative NFkB pathway in different cells." @default.
- W2155204564 created "2016-06-24" @default.
- W2155204564 creator A5004127240 @default.
- W2155204564 creator A5045019377 @default.
- W2155204564 creator A5055467873 @default.
- W2155204564 creator A5069184220 @default.
- W2155204564 creator A5078210269 @default.
- W2155204564 creator A5088666889 @default.
- W2155204564 date "2014-06-23" @default.
- W2155204564 modified "2023-10-17" @default.
- W2155204564 title "Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB" @default.
- W2155204564 cites W1973562447 @default.
- W2155204564 cites W1978019581 @default.
- W2155204564 cites W1984534203 @default.
- W2155204564 cites W1986320887 @default.
- W2155204564 cites W1990089954 @default.
- W2155204564 cites W1993731501 @default.
- W2155204564 cites W2007744512 @default.
- W2155204564 cites W2014582878 @default.
- W2155204564 cites W2017328208 @default.
- W2155204564 cites W2017682198 @default.
- W2155204564 cites W2024969918 @default.
- W2155204564 cites W2028330103 @default.
- W2155204564 cites W2037334368 @default.
- W2155204564 cites W2037646943 @default.
- W2155204564 cites W2040993067 @default.
- W2155204564 cites W2042872424 @default.
- W2155204564 cites W2052634463 @default.
- W2155204564 cites W2058722357 @default.
- W2155204564 cites W2069356140 @default.
- W2155204564 cites W2070135451 @default.
- W2155204564 cites W2086990334 @default.
- W2155204564 cites W2088174145 @default.
- W2155204564 cites W2088540908 @default.
- W2155204564 cites W2090507360 @default.
- W2155204564 cites W2094863064 @default.
- W2155204564 cites W2100772783 @default.
- W2155204564 cites W2101035019 @default.
- W2155204564 cites W2116609506 @default.
- W2155204564 cites W2122044177 @default.
- W2155204564 cites W2131574772 @default.
- W2155204564 cites W2136426653 @default.
- W2155204564 cites W2146502962 @default.
- W2155204564 cites W2151638673 @default.
- W2155204564 cites W2159761055 @default.
- W2155204564 cites W2591250198 @default.
- W2155204564 doi "https://doi.org/10.18632/oncotarget.2128" @default.
- W2155204564 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4147345" @default.
- W2155204564 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24980832" @default.
- W2155204564 hasPublicationYear "2014" @default.
- W2155204564 type Work @default.
- W2155204564 sameAs 2155204564 @default.
- W2155204564 citedByCount "51" @default.
- W2155204564 countsByYear W21552045642014 @default.
- W2155204564 countsByYear W21552045642015 @default.
- W2155204564 countsByYear W21552045642016 @default.
- W2155204564 countsByYear W21552045642017 @default.
- W2155204564 countsByYear W21552045642018 @default.
- W2155204564 countsByYear W21552045642019 @default.
- W2155204564 countsByYear W21552045642020 @default.
- W2155204564 countsByYear W21552045642021 @default.
- W2155204564 countsByYear W21552045642022 @default.
- W2155204564 countsByYear W21552045642023 @default.
- W2155204564 crossrefType "journal-article" @default.
- W2155204564 hasAuthorship W2155204564A5004127240 @default.
- W2155204564 hasAuthorship W2155204564A5045019377 @default.
- W2155204564 hasAuthorship W2155204564A5055467873 @default.
- W2155204564 hasAuthorship W2155204564A5069184220 @default.
- W2155204564 hasAuthorship W2155204564A5078210269 @default.
- W2155204564 hasAuthorship W2155204564A5088666889 @default.
- W2155204564 hasBestOaLocation W21552045641 @default.
- W2155204564 hasConcept C104317684 @default.
- W2155204564 hasConcept C127561419 @default.
- W2155204564 hasConcept C154317977 @default.
- W2155204564 hasConcept C184235292 @default.
- W2155204564 hasConcept C202751555 @default.
- W2155204564 hasConcept C203014093 @default.
- W2155204564 hasConcept C2776364478 @default.
- W2155204564 hasConcept C2776914184 @default.
- W2155204564 hasConcept C2777730290 @default.
- W2155204564 hasConcept C2780007613 @default.
- W2155204564 hasConcept C502942594 @default.
- W2155204564 hasConcept C54355233 @default.
- W2155204564 hasConcept C71924100 @default.
- W2155204564 hasConcept C86803240 @default.
- W2155204564 hasConcept C95444343 @default.
- W2155204564 hasConceptScore W2155204564C104317684 @default.
- W2155204564 hasConceptScore W2155204564C127561419 @default.
- W2155204564 hasConceptScore W2155204564C154317977 @default.
- W2155204564 hasConceptScore W2155204564C184235292 @default.
- W2155204564 hasConceptScore W2155204564C202751555 @default.
- W2155204564 hasConceptScore W2155204564C203014093 @default.
- W2155204564 hasConceptScore W2155204564C2776364478 @default.
- W2155204564 hasConceptScore W2155204564C2776914184 @default.
- W2155204564 hasConceptScore W2155204564C2777730290 @default.
- W2155204564 hasConceptScore W2155204564C2780007613 @default.
- W2155204564 hasConceptScore W2155204564C502942594 @default.
- W2155204564 hasConceptScore W2155204564C54355233 @default.